CRESCENT BIOPHARMA, INC.
For the period ended Dec 2, 2025. Filed Dec 4, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Dec 2, 2025 · Filed Dec 4, 2025
Use the contents to explore the available documents and sections.
CBIO$13.54+4.6%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · Reference:
Reference:
- Xiong A, et al. Lancet. 2025; 405(10481):839-849.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.